<code id='E3611DED2C'></code><style id='E3611DED2C'></style>
    • <acronym id='E3611DED2C'></acronym>
      <center id='E3611DED2C'><center id='E3611DED2C'><tfoot id='E3611DED2C'></tfoot></center><abbr id='E3611DED2C'><dir id='E3611DED2C'><tfoot id='E3611DED2C'></tfoot><noframes id='E3611DED2C'>

    • <optgroup id='E3611DED2C'><strike id='E3611DED2C'><sup id='E3611DED2C'></sup></strike><code id='E3611DED2C'></code></optgroup>
        1. <b id='E3611DED2C'><label id='E3611DED2C'><select id='E3611DED2C'><dt id='E3611DED2C'><span id='E3611DED2C'></span></dt></select></label></b><u id='E3611DED2C'></u>
          <i id='E3611DED2C'><strike id='E3611DED2C'><tt id='E3611DED2C'><pre id='E3611DED2C'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:2
          Mike Belleme for STAT

          Five years after investor-owned HCA Healthcare took over an esteemed nonprofit hospital in North Carolina, Medicare is threatening to cut off payment for any services it provides seniors.

          The rare and dramatic move follows a Medicare revelation that patient safety is in “immediate jeopardy” at Mission Hospital in Asheville. That designation is the most severe the agency can hand out. HCA has just a few weeks to fix the problems or lose its Medicare funding.

          advertisement

          “If on average Medicare pays roughly one-third of your revenue, if they stop paying you, you will die,” said Michael Millenson, a national patient safety expert and president of the consultancy Health Quality Advisors. “That’s why it gets immediate attention from the hospital management, because it’s a death threat.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          The Biogen Aduhelm mess could happen again
          The Biogen Aduhelm mess could happen again

          BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc